Monthly Archives: June, 2025

Tagomics awarded massive grant for detection of colorectal cancer

Tagomics Ltd, a pioneering biomarker discovery and diagnostics company, has announced it has been awarded £860,000 Innovate UK funding as part of the Biomedical...

Partners accelerate novel drug discovery for complex diseases

BioDuro, a trusted global Contract Research, Development, and Manufacturing Organisation, has announced a groundbreaking partnership with Silicogenix, the pioneer of fit-for-purpose small molecule design...

Highlights of the Nutraceuticals roundtable in Cologne

Romaco Kilian recently teamed up with Biogrund, TaBlitz and the Romaco sister companies Innojet and Tecpharm to host a “Nutraceuticals get-together”. The two-day event...

AchemAsia Process Innovation Award

The 2025 AchemAsia Process Innovation Award aims to promote significant advancements in the industry by recognising technological breakthroughs and best practices that support top-class,...

Lilly presents first clinical data for next-generation FRα targeting ADC in platinum-resistant ovarian cancer

At the 2025 ASCO Annual Meeting, Eli Lilly announced new Phase 1 data showing that its folate receptor alpha (FRα) antibody-drug conjugate (ADC) (LY4170156)...

Pain pipeline investment by Eli Lilly

Eli Lilly, a private biotechnology company developing small molecule inhibitors of sodium channels to treat pain and other neuronal hyperexcitability disorders, on 27 May...

Biotech giant announces closure of $65m public offering

Immunic, a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced the closing...

Most Read